Nesher Technologies (NTI) is a nanobiotech company developing a single-molecule detection (SMD) technology. It offers the Alternating Laser EXcitation (ALEX) platform, which is used for multiplexed barcoded detection and quantification of target molecules such as proteins, RNAs, and DNAs in complex samples. Diagnostic application examples include tests for early cancer detection, acute myocardial infarction, osteoarthritis, traumatic brain injury, neurodegenerative diseases such as Alzheimer's, Parkinson's, and other motosensory neuropathies, diabetes, asthma, infectious, and autoimmune diseases, as well as bioterror agents.